Angel Montero Luis

Fast Forward Trial = Ultrahypo# in Breast Cancer 10 year Update Lancet Oncol 2026 Published Online May 14, 2026 doi.org/10.1016/ S1470-2045(26)00192-0

Excellent debate team #ESTRO2026

Long term results of RAPCHEM trial #breast #ESTRO2026

📌This house believes that all patients needing radiotherapy for breast cancer will be treatable in 5️⃣days by 2035!
For the motion - rebuttal ✨ outstanding presentation led by prof @Icro_Meattini 👏🏻 @ESTRO_RT #ESTRO26 @OncoAlert #OncoAlertAF

Day TWO of #ESTRO26 Coverage by OncoAlert 🚨 Long term results of radiation therapy de-escalation in cT1-2N1 breast cancer after primary systemic treatment (RAPCHEM, BOOG 2010-03; NCT01279304) Presented by Fleur Mauritz 🇳🇱 #RadOnc ☢️ Long-term results of tailoring radiotherapy to nodal response after primary chemotherapy in breast cancer are lacking. This prospective registry study of 838 Dutch patients with cT1-2N1 (≤3 suspicious nodes) breast cancer, categorized in three risk-groups (ypN0; ypN1; ≥ypN2) with corresponding radiation strategy, shows that this strategy is feasible with very low 10-year locoregional-recurrence rate in all risk groups, and that tumour subtype seems a valuable target for further treatment adaptation. @ESTRO_RT @yasemin09896924 @LindaMrissa @christian_roenn @Valeriadionisi @gerryhanna @clchiang_hk @mtugceyilmaz @B_Tomasik @gmpetrianni @CiroFranzese1 @Atem84 @piet_ost @brachyexpert @BlanceS90 @The_PT_Explorer @BarbaraJereczek @Mat_Guc @ZilliThomas @AnnaKirby17 @PBlanchardMD @achoud72 Pinging OA faculty @MKnoll_MD @_ShankarSiva @Icro_Meattini @seanmmcbride @NiuSanford @nataliagandur @acampsmalea @to_be_elizabeth

Day TWO of #ESTRO26 Coverage by OncoAlert 🚨 Five-Year Follow-Up of the SABR 5 Trial: Primary Toxicity Analysis of Stereotactic Ablative Radiotherapy for Up to Five Oligometastases Presenter Robert Olson 🇨🇦 SABR-5 is a population-based phase II trial evaluating long-term toxicity of SABR for patients with up to five oligometastases. Among 380 patients treated across a provincial program, five-year follow-up showed low rates of high-grade toxicity, with no late emergence of grade ≥4 events. Most late toxicities were low grade and often persistent rather than new. These findings provide reassurance regarding the long-term safety of SABR in routine clinical practice. #RadOnc @ESTRO_RT @yasemin09896924 @LindaMrissa @christian_roenn @Valeriadionisi @gerryhanna @clchiang_hk @mtugceyilmaz @B_Tomasik @gmpetrianni @CiroFranzese1 @Atem84 @piet_ost @brachyexpert @BlanceS90 @The_PT_Explorer @BarbaraJereczek @Mat_Guc @ZilliThomas @AnnaKirby17 @PBlanchardMD @achoud72 Pinging OA faculty @MKnoll_MD @_ShankarSiva @Icro_Meattini @seanmmcbride @NiuSanford @nataliagandur @acampsmalea @to_be_elizabeth

Mentira.

For those that couldnt make it to #AUA26, especially those at #ESTRO26, here were some of the slides for the "Pro" RT to primary in M1a disease. @TylerSbrt @UroCancer @CaPsurvivorship @PCaParker @Prof_Nick_James @wandering_gu

✨ Meet Our Social Media Ambassadors for the #ESTRO26 Congress ✨ We’re proud to introduce our 41 Social Media Ambassadors, each specialising in a specific area. 🔍 Find the ambassadors aligned with your interests 👉 Discover the full team and start following.

Vender a Morata por 80 millones para quedarse con Benzema es hipotecar el '9' del Madrid. Ya ha jugado los 10 mejores partidos de su carrera

"El mejor periodismo deportivo que se hace en el mundo" se ha indignado más por las palabras de Florentino Pérez que por los millonarios pagos del Barcelona al Negreira durante 17 años.

Comunicado oficial: la Justicia da la razón al Real Madrid en el caso de los conciertos en el Bernabéu.

@alandete Pues es una mierda de columna. Si he de decirte la verdad. Una mierda antimadridista más.

Can’t wait. And you? Are you ready? Can #breastcancer #radiotherapy be delivered in just 5 days by 2035? ⏱️ Join the debate at #ESTRO26 Anna Kirby vs Birgitte Offersen Rebuttals: Icro Meattini & David Krug 📅 May 16 | 15:15–16:30 📍 A1 Plenary #OncoAlert @OncoAlert @ESTRO_RT

El XXIII Congreso Nacional #SEOR2026 contaremos con la participación del Prof. @JoeChangMD en la sesión magistral: Evidence for SBRT and Proton Therapy in Lung Cancer. Alicante | 📅 3–5 junio 2026 congresoseor.es/seor2026 #SEOR2026 #OncologíaRadioterápica #Protonterapia

Case Report: Successful Reirradiation of Multiply Recurrent Lymphocytic Hypophysitis 🔗 Full case details: zurl.co/kJhOw #RadOnc #RadiationOncology #CancerCare #CaseStudy #RadOncEd #MedEd

ESTRO Elections 2026 #radonc @SEOR_ESP

Really? Isn’t an editorial an opinion piece @DriesDeveltere? I hope you realise that if you used the same CTCAE scale for grading cumulative toxicity, you would have 100% G2+ indefinitely with prostatectomy…. Plenty of #radonc talk about these 2 trials cumulative AEs, which you would know if you had bothered to collaborate with one to write this editorial/opinion piece….

10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial - European Urology europeanurology.com/article/S0302-…

Esto de David Mejía merece estar en abierto. Mis disculpas por los pantallazos. 👇👇👇